CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)

Yazar
Heidenreich, A.
Parente, P.
de Schultz, W.
Gerritsen, W. R.
Anton Aparicio, L. M.
Malik, Z. I.
Di Lorenzo, G.
Basaran, M.
Hitier, S.
Bahl, A.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/21014
Koleksiyonlar